# China targets first-in-class drugs exceeding 25% of global total by 2030

https://mins.news/en/item/65050

- China News Service, 2026-09-18 03:20 UTC
- Science
- Original: http://www.ecns.cn/cns-wire/2026-09-19/detail-ihfkhtke4053609.shtml

> China’s pharmaceutical industry development plan for the 2026-2030 period aims for the country’s first-in-class new drugs to exceed 25% of the global total by 2030. It also targets more than 3.5 trillion yuan in revenue from large pharmaceutical manufacturers, annual innovative-drug growth above 20%, and at least 50 companies with revenue exceeding 10 billion yuan.

## Related coverage

- [China targets global forefront with 25% of first-in-class drugs by 2030](https://mins.news/en/item/63862) — South China Morning Post, 2026-09-18
- [China unveils five-year plan for electronic information manufacturing](https://mins.news/en/item/60252) — CGTN, 2026-09-15